Welcome to the Oncomine Blog

University of Munich Evaluates the Oncomine Comprehensive Plus Assay for HRD Detection

09/22/2021

Our OncomineWorld event in 2021 brought thousands of professionals together from around the world to advance our understanding of next-generation sequencing (NGS) in precision oncology research. By enabling simultaneous, comprehensive genomic..

Case Study: High-Quality, Cost-Effective Genomic ...

In a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at ...

Q&A: An Inside Look at Immune Repertoire Assay ...

Dr. Geoffrey Lowman Senior Staff Scientist, Molecular Biology, Clinical Sequencing Division Thermo ...

UAB Study Evaluates the Oncomine Myeloid Research ...

Performance of the Oncomine Myeloid Research Assay GX Craig Mackinnon, MD, PhD, Director of Genomic ...

Let’s Do It Ourselves - A global expert consensus ...

Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have ...

A Comprehensive Answer for Cancer: Is ...

What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of ...

Biomarker Tests for Precision Oncology: DIY or ...

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage ...

Evaluating the Oncomine Myeloid Assay GX for ...

Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of ...

What is Comprehensive Genomic Profiling & is it ...

What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the ...

The Importance of Detecting Copy Number Variants ...

Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy ...